Currently out of the existing stock ratings of Vik Chopra, 12 are a HOLD (57.14%), 9 are a BUY (42.86%).

Vik Chopra

Work Performance Price Targets & Ratings Chart

Analyst Vik Chopra, currently employed at WELLS FARGO, carries an average stock price target met ratio of 68.06% that have a potential upside of 10.28% achieved within 137 days.

Vik Chopra’s has documented 43 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GMED, Globus Medical at 06-Nov-2024.

Wall Street Analyst Vik Chopra

Analyst best performing recommendations are on MASI (MASIMO).
The best stock recommendation documented was for MASI (MASIMO) at 8/9/2023. The price target of $110 was fulfilled within 7 days with a profit of $7.96 (6.75%) receiving and performance score of 9.64.

Average potential price target upside

ENOV Enovis Corp GMED Globus Medical MASI Masimo NUVA NuVasive

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$65

$18.33 (39.28%)

$65

17 days ago
(07-Nov-2024)

1/10 (10%)

$17.14 (35.81%)

106

Buy

$58

$11.33 (24.28%)

$62

1 months 23 days ago
(01-Oct-2024)

0/4 (0%)

$16.37 (39.32%)

Buy

$79

$32.33 (69.27%)

$67

9 months 1 days ago
(23-Feb-2024)

2/4 (50%)

$16.15 (25.70%)

118

Buy

$75

$28.33 (60.70%)

$68

1 years 1 months 4 days ago
(20-Oct-2023)

0/2 (0%)

$30.53 (68.65%)

Buy

$70

$23.33 (49.99%)

$64

1 years 3 months 20 days ago
(04-Aug-2023)

1/5 (20%)

$10.77 (18.18%)

126

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Vik Chopra is most bullish on?

Potential upside of $3.28 has been obtained for GMED (GLOBUS MEDICAL)

Which stock is Vik Chopra is most reserved on?

Potential downside of -$1.1 has been obtained for MASI (MASIMO)

What Year was the first public recommendation made by Vik Chopra?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?